Obesity, Type 2 Diabetes, Lifestyle Factors, and Risk of Gallstone Disease: A Mendelian Randomization Investigation

Background & Aims: Obesity, type 2 diabetes, and lifestyle factors (cigarette smoking, alcohol drinking, and coffee consumption) have been associated with the risk of developing gallstone disease in observational studies, but whether these associations are causal is undetermined. We conducted a...

Full description

Bibliographic Details
Main Authors: Gill, D. (Author), Giovannucci, E.L (Author), Larsson, S.C (Author), Yuan, S. (Author)
Format: Article
Language:English
Published: W.B. Saunders 2022
Subjects:
Online Access:View Fulltext in Publisher
LEADER 03878nam a2200685Ia 4500
001 10-1016-j-cgh-2020-12-034
008 220420s2022 CNT 000 0 und d
020 |a 15423565 (ISSN) 
245 1 0 |a Obesity, Type 2 Diabetes, Lifestyle Factors, and Risk of Gallstone Disease: A Mendelian Randomization Investigation 
260 0 |b W.B. Saunders  |c 2022 
856 |z View Fulltext in Publisher  |u https://doi.org/10.1016/j.cgh.2020.12.034 
520 3 |a Background & Aims: Obesity, type 2 diabetes, and lifestyle factors (cigarette smoking, alcohol drinking, and coffee consumption) have been associated with the risk of developing gallstone disease in observational studies, but whether these associations are causal is undetermined. We conducted a Mendelian randomization study to assess these associations. Methods: Genetic instruments associated with the exposures at the genome-wide significance (p < 5×10−8) level were selected from corresponding genome-wide association studies (n=224 459 to 1 232 091 individuals). Summary-level data for gallstone disease were obtained from the UK Biobank (10 520 cases and 350 674 non-cases) and FinnGen consortium (11 675 cases and 121 348 non-cases). Univariable and multivariable Mendelian randomization analyses were conducted. Results from UK Biobank and FinnGen were combined using fixed-effects meta-analysis. Results: The odds ratios were 1.63 (95% confidence interval (CI), 1.49, 1.79) for one standard deviation (SD) increase in body mass index, 1.81 (95% CI, 1.60, 2.05) for one SD increase in waist circumference, 1.13 (95% CI, 1.09, 1.17) for one unit increase in the log-odds ratio of type 2 diabetes and 1.25 (95% CI, 1.16, 1.34) for one SD increase in prevalence of smoking initiation. The associations for body mass index and type 2 diabetes persisted after mutual adjustment. Genetically predicted coffee consumption was inversely associated with gallstone disease after adjustment for body mass index and smoking (odds ratio per 50% increase 0.44, 95% CI, 0.21, 0.91). There was no association with alcohol consumption. Conclusions: This study supports independent causal roles of obesity, type 2 diabetes, and smoking in gallstone disease. © 2022 The Authors 
650 0 4 |a abdominal obesity 
650 0 4 |a Article 
650 0 4 |a biobank 
650 0 4 |a body mass 
650 0 4 |a cholelithiasis 
650 0 4 |a cholelithiasis 
650 0 4 |a Cholelithiasis 
650 0 4 |a cigarette smoking 
650 0 4 |a coffee consumption 
650 0 4 |a cohort analysis 
650 0 4 |a controlled study 
650 0 4 |a Diabetes Mellitus, Type 2 
650 0 4 |a disease association 
650 0 4 |a Gallstones 
650 0 4 |a genetic predisposition 
650 0 4 |a Genetic Predisposition to Disease 
650 0 4 |a genetics 
650 0 4 |a genome-wide association study 
650 0 4 |a Genome-Wide Association Study 
650 0 4 |a human 
650 0 4 |a Humans 
650 0 4 |a Life Style 
650 0 4 |a lifestyle 
650 0 4 |a lifestyle 
650 0 4 |a Lifestyle Factors 
650 0 4 |a major clinical study 
650 0 4 |a Mendelian randomization analysis 
650 0 4 |a Mendelian randomization analysis 
650 0 4 |a Mendelian Randomization Analysis 
650 0 4 |a meta analysis 
650 0 4 |a non insulin dependent diabetes mellitus 
650 0 4 |a non insulin dependent diabetes mellitus 
650 0 4 |a obesity 
650 0 4 |a Obesity 
650 0 4 |a Polymorphism, Single Nucleotide 
650 0 4 |a prevalence 
650 0 4 |a risk factor 
650 0 4 |a risk factor 
650 0 4 |a Risk Factors 
650 0 4 |a single nucleotide polymorphism 
650 0 4 |a Type 2 Diabetes 
650 0 4 |a United Kingdom 
650 0 4 |a waist circumference 
700 1 0 |a Gill, D.  |e author 
700 1 0 |a Giovannucci, E.L.  |e author 
700 1 0 |a Larsson, S.C.  |e author 
700 1 0 |a Yuan, S.  |e author 
773 |t Clinical Gastroenterology and Hepatology